GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

dapirolizumab pegol   Click here for help

GtoPdb Ligand ID: 11123

Synonyms: CDP-7657 | CDP7657 | DZP
Immunopharmacology Ligand
Compound class: Antibody
Comment: Dapirolizumab pegol (CDP7657) is a pegylated monovalent Fab' immunomodulator that targets CD40 ligand [1]. It was developed by UCB Pharma. Removal of the Fc domain prevented the increased risk of thrombotic events observed with an intact mAb.
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
9869 dapirolizumab pegol
Synonyms Click here for help
CDP-7657 | CDP7657 | DZP
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 481
Other databases
CAS Registry No. 1416147-64-2 (source: WHO INN record)
ChEMBL Ligand CHEMBL2109478
GtoPdb PubChem SID 434122183
Search PubMed clinical trials dapirolizumab pegol
Search PubMed titles dapirolizumab pegol
Search PubMed titles/abstracts dapirolizumab pegol